ClinicalTrials.gov record
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
ClinicalTrials.gov ID: NCT00146328
Public ClinicalTrials.gov record NCT00146328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to determine the long term safety and tolerability of multiple oral doses of tipranavir (Aptivus) and ritonavir with a focus on the long term safety of the development dose (500 mg tipranavir/200 mg ritonavir BID) when administered with other antiretroviral medications.
Study identification
- NCT ID
- NCT00146328
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 997 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2001
- Primary completion
- Apr 30, 2008
- Completion
- Not listed
- Last update posted
- Mar 5, 2014
Started 2001
United States locations
- U.S. sites
- 86
- U.S. states
- 29
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1182.17.39 MDS Pharma Services | Phoenix | Arizona | — | — |
| 1182.17.75 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 1182.17.89 Boehringer Ingelheim Investigational Site | Berkeley | California | — | — |
| 1182.17.60 Boehringer Ingelheim Investigational Site | Fountain Valley | California | — | — |
| 1182.17.106 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.17.15 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.17.40 Tower ID Medical | Los Angeles | California | — | — |
| 1182.17.46 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.17.47 University of Southern California | Los Angeles | California | — | — |
| 1182.17.73 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1182.17.114 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 1182.17.128 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 1182.17.37 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 1182.17.58 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 1182.17.96 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 1182.17.87 Boehringer Ingelheim Investigational Site | Norwalk | Connecticut | — | — |
| 1182.17.112 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 1182.17.43 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 1182.17.65 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 1182.17.126 Boehringer Ingelheim Investigational Site | Fort Lauderdale | Florida | — | — |
| 1182.17.8 Boehringer Ingelheim Investigational Site | Fort Myers | Florida | — | — |
| 1182.17.131 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1182.17.22 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1182.17.64 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 1182.17.129 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 1182.17.51 Boehringer Ingelheim Investigational Site | South Miami | Florida | — | — |
| 1182.17.125 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 1182.17.132 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 1182.17.76 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 1182.17.52 Boehringer Ingelheim Investigational Site | Vero Beach | Florida | — | — |
| 1182.17.77 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 1182.17.69 Boehringer Ingelheim Investigational Site | Macon | Georgia | — | — |
| 1182.17.136 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1182.17.70 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 1182.17.36 Boehringer Ingelheim Investigational Site | Evanston | Illinois | — | — |
| 1182.17.1 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 1182.17.32 University of Kansas School of Medicine - Wichita | Wichita | Kansas | — | — |
| 1182.17.102 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 1182.17.21 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 1182.17.30 Boehringer Ingelheim Investigational Site | Portland | Maine | — | — |
| 1182.17.67 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1182.17.86 Boehringer Ingelheim Investigational Site | Bethesda | Maryland | — | — |
| 1182.17.111 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 1182.17.63 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 1182.17.74 Boehringer Ingelheim Investigational Site | Springfield | Massachusetts | — | — |
| 1182.17.4 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | — | — |
| 1182.17.115 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 1182.17.6 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 1182.17.62 Boehringer Ingelheim Investigational Site | Kansas City | Missouri | — | — |
| 1182.17.59 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 1182.17.118 Early Intervention Program (EIP) Clinic | Camden | New Jersey | — | — |
| 1182.17.93 Boehringer Ingelheim Investigational Site | East Orange | New Jersey | — | — |
| 1182.17.24 Hackensack University Medical Center | Hackensack | New Jersey | — | — |
| 1182.17.34 ID Care, Inc. | Hillsborough | New Jersey | — | — |
| 1182.17.50 Boehringer Ingelheim Investigational Site | Santa Fe | New Mexico | — | — |
| 1182.17.79 Boehringer Ingelheim Investigational Site | Albany | New York | — | — |
| 1182.17.103 Boehringer Ingelheim Investigational Site | Mount Vernon | New York | — | — |
| 1182.17.105 Pollari Medical Group | New York | New York | — | — |
| 1182.17.130 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.17.3 Division of Infectious Diseases | New York | New York | — | — |
| 1182.17.42 Beth Israel Medical Center | New York | New York | — | — |
| 1182.17.5 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.17.7 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.17.94 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 1182.17.135 Boehringer Ingelheim Investigational Site | Rochester | New York | — | — |
| 1182.17.31 Boehringer Ingelheim Investigational Site | Stony Brook | New York | — | — |
| 1182.17.53 Boehringer Ingelheim Investigational Site | Durham | North Carolina | — | — |
| 1182.17.54 Boehringer Ingelheim Investigational Site | Huntersville | North Carolina | — | — |
| 1182.17.134 Summa Health System | Akron | Ohio | — | — |
| 1182.17.95 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1182.17.26 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 1182.17.9 Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| 1182.17.110 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1182.17.99 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1182.17.23 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 1182.17.11 Boehringer Ingelheim Investigational Site | Memphis | Tennessee | — | — |
| 1182.17.18 Vanderbilt AIDS Clinical Trials Center | Nashville | Tennessee | — | — |
| 1182.17.116 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 1182.17.142 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 1182.17.16 Nelson-Tebedo Clinic | Dallas | Texas | — | — |
| 1182.17.122 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1182.17.68 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1182.17.97 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1182.17.10 Boehringer Ingelheim Investigational Site | Annandale | Virginia | — | — |
| 1182.17.92 Boehringer Ingelheim Investigational Site | Tacoma | Washington | — | — |
| 1182.17.100 Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 147 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00146328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00146328 live on ClinicalTrials.gov.